Nominal Boost in HF Biomarkers With Vericiguat

ACC Conference Reporter

AHA 2015 | ORLANDO, FL — Patients treated with vericiguat for worsening chronic heart failure (HF) showed modest improvement at higher doses of the drug, according to a phase II study. Read More >>>

Keywords: AHA Annual Scientific Sessions


< Back to Listings